Literature DB >> 14751282

Early increase of apoptosis-linked gene-2 interacting protein X in areas of kainate-induced neurodegeneration.

F J Hemming1, S Fraboulet, B Blot, R Sadoul.   

Abstract

Apoptosis-linked gene-2 interacting protein X (Alix) is thought to be involved in both cell death and vesicular trafficking. We examined Alix expression 2 h, 6 h and 24 h after triggering seizure-dependent neuronal death by i.p. kainic acid injection. In the hippocampus, intense, transient immunolabelling was observed in the strata lucidum, oriens and radiatum, areas of high synaptic activity. The similarity of this distribution to those of synaptophysin and endophilin suggests a presynaptic localisation. Alix labelling was increased in neuronal cell bodies in kainate-sensitive regions before or concomitant with the first signs of oedema and/or neuronal eosinophilia. The increase persisted 24 h after kainate-injection in CA3 and the piriform cortex which are areas with massive swelling and numerous pyknotic neurons. This suggests that Alix may play an early role in the mechanisms leading to cell death. Taken together, our results suggest that Alix may be a molecular link between synaptic functioning and neuronal death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751282     DOI: 10.1016/j.neuroscience.2003.10.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Autophagy discriminates between Alix and ESCRTs.

Authors:  Anne Petiot; Rémy Sadoul
Journal:  Autophagy       Date:  2009-01-28       Impact factor: 16.016

2.  ALIX increases protein content and protective function of iPSC-derived exosomes.

Authors:  Ruiting Sun; Yingying Liu; Meng Lu; Qianqian Ding; Pingping Wang; Heng Zhang; Xiaoyu Tian; Peng Lu; Dan Meng; Ning Sun; Meng Xiang; Sifeng Chen
Journal:  J Mol Med (Berl)       Date:  2019-04-03       Impact factor: 4.599

3.  Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a Drosophila Alzheimer's disease model.

Authors:  Sheila K Pirooznia; Jessica Sarthi; Ashley A Johnson; Meridith S Toth; Kellie Chiu; Sravanthi Koduri; Felice Elefant
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

Review 4.  Cell death in development, maintenance, and diseases of the nervous system.

Authors:  Sourav Ghosh; Carla V Rothlin; Maria E Mercau; Siraj Patwa; Krishna P L Bhat
Journal:  Semin Immunopathol       Date:  2022-05-04       Impact factor: 11.759

5.  Neuronal Functions of ESCRTs.

Authors:  Jin-A Lee; Fen-Biao Gao
Journal:  Exp Neurobiol       Date:  2012-02-28       Impact factor: 3.261

6.  Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.

Authors:  Diederick Duijvesz; Kristin E Burnum-Johnson; Marina A Gritsenko; A Marije Hoogland; Mirella S Vredenbregt-van den Berg; Rob Willemsen; Theo Luider; Ljiljana Paša-Tolić; Guido Jenster
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Tumor susceptibility gene 101 regulates predisposition to apoptosis via ESCRT machinery accessory proteins.

Authors:  Zenia Kaul; Oishee Chakrabarti
Journal:  Mol Biol Cell       Date:  2017-05-24       Impact factor: 4.138

8.  The Novel ALG-2 Target Protein CDIP1 Promotes Cell Death by Interacting with ESCRT-I and VAPA/B.

Authors:  Ryuta Inukai; Kanako Mori; Keiko Kuwata; Chihiro Suzuki; Masatoshi Maki; Terunao Takahara; Hideki Shibata
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

9.  ALG-2 activates the MVB sorting function of ALIX through relieving its intramolecular interaction.

Authors:  Sheng Sun; Xi Zhou; Joe Corvera; Gary E Gallick; Sue-Hwa Lin; Jian Kuang
Journal:  Cell Discov       Date:  2015-07-21       Impact factor: 10.849

10.  Interplay of TRIM2 E3 Ubiquitin Ligase and ALIX/ESCRT Complex: Control of Developmental Plasticity During Early Neurogenesis.

Authors:  Ashwin Lokapally; Herbert Neuhaus; Juliane Herfurth; Thomas Hollemann
Journal:  Cells       Date:  2020-07-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.